Library of Ashurbanipal · MELEK

Library›Substances and pharmacology›Catecholamines Transporters and Monoamine Reuptake

Catecholamines Transporters and Monoamine Reuptake

Catecholamines, Transporters, and Monoamine Reuptake provides an exhaustive chemical and pharmacological reference on the mammalian catecholamine cascade, trace amine systems, monoamine transporters (SERT, DAT, NET), and the neurochemical mechanisms governing the spectrum from restful sleep to stimulant-induced psychotic wakefulness.

The Catecholamine Biosynthetic Cascade

The catecholamines are bio-active amines characterized by a central benzene ring bearing two adjacent hydroxyl groups (a catechol nucleus at positions 3 and 4) attached to an ethylamine side chain:

<code>

[ L-Phenylalanine ] (Essential Amino Acid)

│ (Phenylalanine Hydroxylase / PAH)

▼

[ L-Tyrosine ] ──────────────────────────────────────────► [ Thyroid Hormones: T3 & T4 ]

│ (Tyrosine Hydroxylase / TH — Rate-Limiting Step) (Iodinated Tyrosine Dimers)

▼

[ L-DOPA (L-3,4-Dihydroxyphenylalanine) ]

│ (Aromatic L-Amino Acid Decarboxylase / AADC)

▼

[ Dopamine (3,4-Dihydroxyphenethylamine) ] ──► [ Motivation, Salience, Motor Control (D1–D5) ]

│ (Dopamine β-Hydroxylase / DBH — Inside Synaptic Vesicles)

▼

[ Norepinephrine (Noradrenaline) ] ──────────► [ Vigilance, Sympathetic Tone, Arousal (α/β Adrenergic) ]

│ (Phenylethanolamine N-Methyltransferase / PNMT — Adrenal Medulla)

▼

[ Epinephrine (Adrenaline) ] ────────────────► [ Systemic Fight-or-Flight Hormone ]

</code>

Trace Amines, Invertebrate Neurochemistry, and Natural Ephedrines

Alongside the primary catecholamines exists a family of endogenous trace amines synthesized from the same aromatic amino acids:

{| class="wikitable"

! Molecule !! Chemical Structure !! Primary Source / System !! Target Receptor !! Physiological Function

|-

| Octopamine || 4-Hydroxyphenylethanolamine || Invertebrates (Insects/Mollusks), Citrus aurantium, brewing || Arthropod Octopamine GPCRs; Human TAAR1 || The "Arthropod Adrenaline"—mediates fight-or-flight, sting release, and foraging in bees/locusts; metabolic trace amine in humans.

|-

| Tyramine || 4-Hydroxyphenethylamine || Fermented foods, cheeses, aged meats, human tissues || TAAR1, vesicular displacement || Indirect sympathomimetic; triggers norepinephrine release; causes hypertensive crisis when MAO-A is inhibited.

|-

| Synephrine || 4-Hydroxy-$N$-methylphenylethanolamine || Bitter Orange (Citrus aurantium) || $\alpha_1$, $\beta_3$ Adrenergic receptors, TAAR1 || Thermogenesis, lipolysis, mild cardiovascular stimulation without crossing the blood-brain barrier.

|-

| $\beta$-Phenethylamine (PEA) || Unsubstituted Phenethylamine || Human brain, cocoa, microbial decarboxylation || TAAR1 (High Affinity) || "The Endogenous Amphetamine"—potent trigger of dopamine release; metabolized in minutes by MAO-B.

|-

| Ephedrine || $\beta$-Hydroxy-$\alpha$-methylphenethylamine || Ephedra sinica (Ma Huang) || Direct $\alpha$/$\beta$ Adrenergic agonist + NET releaser || Bronchodilation, CNS stimulation, classical botanical bridge to synthetic amphetamines.

|}

1. Octopamine: The Insect Equivalent of Norepinephrine

2. Ephedrine: The Natural Plant-to-Amphetamine Bridge

: <code>Ephedrine: C6H5─CH(OH)─CH(CH3)─NH(CH3) &nbsp;──[ Reductive Dehydroxylation ]──►&nbsp; Methamphetamine: C6H5─CH2─CH(CH3)─NH(CH3)</code>

Transporters and the Reuptake Inhibitor Spectrum

Synaptic neurotransmission is terminated by high-affinity plasma membrane monoamine transporters that pump extracellular transmitter back into the presynaptic terminal:

Therapeutic and recreational substances modulate these transporters across a clear spectrum of selectivity:

<code>

[ THE REUPTAKE INHIBITOR HIERARCHY ]

│

┌──────────────────────────┼──────────────────────────┐

▼ ▼ ▼

[ SSRI ] [ SNRI ] [ SNDRI ]

(Selective Serotonin) (Serotonin-Norepinephrine) (Triple Reuptake)

• Fluoxetine (Prozac) • Venlafaxine (Effexor) • Cocaine (Natural Tropane)

• Sertraline (Zoloft) • Duloxetine (Cymbalta) • Mazindol / Tesofensine

• Pure SERT blockade • Dual SERT + NET • Broad SERT + NET + DAT

</code>

1. SSRIs (Selective Serotonin Reuptake Inhibitors)

2. SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

3. SNDRIs (Triple Reuptake Inhibitors / Cocaine)

** By blocking DAT, it prevents dopamine clearance in the nucleus accumbens, reinforcing addictive reward loops.

** By blocking NET, it drives sharp peripheral tachycardia, pupillary dilation, and hypertension.

** By blocking SERT, it enhances sensory salience.

** Crucially, cocaine also blocks voltage-gated sodium channels ($Na_v$), conferring local anesthetic properties and pro-arrhythmic cardiac toxicity independent of its transporter action.

Reuptake Blockers vs. Substrate Releasing Agents

The central divide in psychostimulant pharmacology is the mechanical distinction between reuptake blockers (cocaine, methylphenidate) and substrate releasing agents (amphetamine, methamphetamine, MDMA):

<code>

[ REUPTAKE BLOCKER (e.g. Cocaine) ] [ SUBSTRATE RELEASER (e.g. Methamphetamine) ]

Presynaptic Terminal Presynaptic Terminal

┌──────────────────────┐ ┌──────────────────────┐

│ │ │ Meth enters via DAT │

│ [Vesicle Intact] │ │ [Vesicle Collapsed]│

│ (Dopamine Stored) │ │ (VMAT2 Reversed) │

│ │ │ Dopamine in Cytosol │

└──────────┬───────────┘ └──────────┬───────────┘

│ │

[DAT Blocked at Pore] [DAT Reversed / Efflux]

│ │

▼ ▼

Dopamine clearance stopped Massive dopamine forced out

(Dependent on native firing) (Independent of action potentials)

</code>

1. Reuptake Blockers (Pore Occlusion)

2. Substrate Releasers (VMAT2 Collapse and Transporter Reversal)

  1. Transporter Hijacking: Amphetamine is transported *into* the presynaptic cytoplasm by DAT and NET.
  2. VMAT2 Collapse: Once inside, amphetamine is a weak base that diffuses across vesicular membranes into storage vesicles. It collapses the intra-vesicular proton gradient ($\Delta pH$) and competitively inhibits the Vesicular Monoamine Transporter 2 (VMAT2).
  3. Cytosolic Flooding: Deprived of the proton motive force required to trap monoamines, thousands of dopamine molecules leak out of the ruptured vesicular stores into the presynaptic cytoplasm.
  4. Transporter Phosphorylation and Reversal: Amphetamine activates intracellular protein kinase C ($\text{PKC}$) and CaMKII, phosphorylating DAT. This flips the transporter into an outward-facing conformation: DAT runs in reverse, pumping massive floodgates of cytosolic dopamine backward across the membrane into the synaptic cleft.

Functional Monoamine Balance: Sleepiness vs. Psychotic Wakefulness

Conscious experience and the sleep-wake continuum are governed by the dynamic equilibrium between serotonergic, dopaminergic, and noradrenergic tone:

<code>

[ GABA / Adenosine / Melatonin ] ──► [ Sedation / NREM Sleep ]

▲

│

[ Balanced 5-HT / DA / NE Tone ] ──► [ Relaxed Alertness / Focus ]

│

▼

[ Elevated Norepinephrine ] ───────► [ Hyper-Adrenergic Tension / Insomnia ]

│

▼

[ Excessive Dopamine + NE ] ───────► [ PSYCHOTIC WAKEFULNESS ]

• Aberrant salience & hyper-vigilance

• Auditory hallucinations & paranoia

• Delusional pattern recognition

</code>

1. Norepinephrine: The Vigilance Gate

2. Dopamine: The Salience Engine

3. Serotonin: The Impulse and Mood Stabilizer

4. The Path to "Psychotic Wakefulness" (Stimulant Psychosis)

When high doses of substrate-releasing stimulants (methamphetamine, high-dose amphetamine) or intensive SNDRIs (cocaine binges) are maintained over 48 to 72 hours without sleep, the brain transitions from functional stimulation into psychotic wakefulness:

See also: Structure-Activity Relationships in Psychopharmacology · The Tryptamine Family and Endogenous Neurochemistry · David E Nichols, Entactogen Pharmacology, and Receptor Mapping · Ecstasy Pill Forensics and Historical Adulteration Trends · Shulgin Ten Essential Amphetamines and Metabolic Chemistry · Molar Stoichiometry, Powder Density, and Tolerance Kinetics · Mucuna Pruriens · Stack Substances

Filed under  Substances and pharmacologyOrganic chemistry and synthesis